| Literature DB >> 31770423 |
Bruno P Moura1, Rogério L Rufino1, Ricardo C Faria2, Paulo Roberto S Amorim2.
Abstract
Increasing prevalence of sedentary behavior (SB) combined with low levels of physical activity (PA) in children and adolescents has become a growing public health concern. Therefore, this study aimed to identify the daily behavioral pattern of adolescents and examine the isotemporal substitution effects of SB with light-intensity PA (LIPA) or moderate-to-vigorous PA (MVPA) on cardiometabolic markers. In this cross-sectional study, the daily behavioral pattern of Brazilian male adolescents was objectively measured for 7 days. Vector magnitude activity counts were used to estimate SB, LIPA, and MVPA with cut-points specifically validated for youth. The isotemporal substitution model was used to assess the effects of replacing different SB bouts (5, 10, 30, and 60 min) with LIPA or MVPA on cardiometabolic markers [body mass index, waist circumference, body fat percentage (BF%), total cholesterol, high-density lipoprotein cholesterol (HDL-C), non-HDL-C, low-density lipoprotein cholesterol, triglyceride (TG), glucose, insulin, homeostatic model assessment of insulin resistance (HOMA2-IR), insulin sensitivity (HOMA2-S), beta cell function (HOMA2-β), systolic-blood pressure (SBP), diastolic-blood pressure, and cardiometabolic risk score]. Male adolescents (n = 84; age, 16.7 ± 0.9 years) wore the GT3X+ for 6.7 ± 0.6 days, during 15.2 ± 2.3 h, and spent 72.9% of the time in SB, 17.3% in LIPA, and 9.8% in MVPA. SB replacement with LIPA was associated with increased HDL-C, TG, HOMA2-IR, and HOMA2-S and decreased SBP. In contrast, SB replacement with MVPA was associated with decreased BF%. Therefore, our findings suggest that replacing SB with LIPA showed positive results on HDL-C, HOMA2-S and SBP, while replacing SB with MVPA was associated with only one obesity indicator (BF%). Moreover, participants met the daily MVPA recommendations, but they still had a daily behavioral pattern with high SB. In this context, LIPAs can be considered an effective alternative to reduce SB and improve the health indicators of this population.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31770423 PMCID: PMC6879145 DOI: 10.1371/journal.pone.0225856
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographic, biochemical, physiological, and accelerometer data for study participants.
(n = 84).
| Mean | (SD) | Median | (IQR) | |
|---|---|---|---|---|
| Age (years) | 16.7 | (0.9) | 16.8 | (1.3) |
| Weight (kg) | 62.6 | (9.5) | 61.0 | (9.5) |
| Height (m) | 1.7 | (0.1) | 1.7 | (0.1) |
| BMI (kg·m-2) | 20.6 | (2.9) | 20.4 | (2.8) |
| WC (cm) | 73.5 | (6.6) | 72.0 | (7.2) |
| BF% | 24.3 | (3.7) | 24.1 | (4.3) |
| Total cholesterol (mmol/L) | 4.1 | (0.6) | 4.1 | (0.9) |
| HDL-C (mmol/L) | 1.1 | (0.2) | 1.1 | (0.3) |
| Non-HDL-C (mmol/L) | 3.0 | (0.6) | 3.0 | (0.8) |
| LDL-C (mmol/L) | 2.5 | (0.5) | 2.5 | (0.7) |
| TG (mmol/L) | 1.0 | (0.3) | 1.0 | (0.4) |
| Glucose (mmol/L) | 4.3 | (0.4) | 4.3 | (0.6) |
| Insulin (pmol/L) | 51.1 | (41.0) | 35.2 | (43.5) |
| HOMA2-β (%) | 119.8 | (70.4) | 102.4 | (64.8) |
| HOMA2-S (%) | 178.6 | (118.4) | 156.7 | (141.5) |
| HOMA2-IR | 0.9 | (0.7) | 0.6 | (0.8) |
| SBP (mmHg) | 111.3 | (11.2) | 111.0 | (16.8) |
| DBP (mmHg) | 72.4 | (7.8) | 72.0 | (10.8) |
| Cardiometabolic risk score | 0.0 | (0.4) | 0.0 | (0.5) |
| DAT (hours) | 15.2 | (2.3) | 14.8 | (2.8) |
| Accelerometer valid days | 6.7 | (0.6) | 7.0 | (0.0) |
| SB (min·day-1) | 667.6 | (129.8) | 640.9 | (152.0) |
| LIPA (min·day-1) | 156.9 | (38.3) | 148.7 | (52.6) |
| MVPA (min·day-1) | 87.8 | (22.7) | 87.4 | (26.0) |
| SB (% of DAT) | 72.9 | (5.7) | 73.2 | (8.8) |
| LIPA (% of DAT) | 17.3 | (3.8) | 17.0 | (6.0) |
| MVPA (% of DAT) | 9.8 | (2.8) | 9.8 | (3.7) |
BMI, body mass index; WC, waist circumference; BF%, body fat percentage; HDL-C, high-density lipoprotein cholesterol; Non-HDL-C, non-High-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglyceride; HOMA2-β, homeostatic model assessment of beta cell function; HOMA2-S, homeostatic model assessment of insulin sensitivity; HOMA2-IR, homeostatic model assessment of insulin resistance; SBP, systolic-blood pressure; DBP, diastolic-blood pressure; DAT, daily awake time; SB, sedentary behavior; LIPA, light-intensity physical activity; MVPA, moderate-to-vigorous physical activity; SD, standard deviation; IQR, interquartile range.
Fig 1Participant daily behavioral patterns.
(A) Summaries of SB, LIPA, and MVPA distributions in hourly blocks for each day. (B) Summaries of SB, LIPA, and MVPA distributions as averages across valid days of the week. SB, sedentary behavior; LIPA, light-intensity physical activity; MVPA, moderate-to-vigorous physical activity.
Fig 2Effects of isotemporal substitution of SB with LIPA or MVPA on cardiometabolic markers.
(A) HDL-C, high-density lipoprotein cholesterol. (B) TG, triglyceride. (C) HOMA2-IR, homeostatic model assessment of insulin resistance. (D) HOMA2-S, homeostatic model assessment of insulin sensitivity. (E) SBP, systolic-blood pressure. (F) BF%, body fat percentage; SB, sedentary behavior; LIPA, light-intensity physical activity; MVPA, moderate-to-vigorous physical activity; CI, confidence interval.aAdjusted for daily awake time (hours), accelerometer valid days, age, smoking status, and body mass index (BMI) (except when BMI was the dependent variable).HDL-C, TG, HOMA2-IR, and HOMA2-S data were transformed from natural log scale for better interpretation.Δβ = β60 - β5 and % represents the increase or decrease from β5.Dotted line represents the linear trend over all bouts.